BARE LASER FIBER MODELS DBLF-40, DBLF-60, DBLF-60-1, DCLF-600B, DSLF-60, DBLF-100
K030959 · Laser Peripherals, LLC · GEX · Apr 25, 2003 · General, Plastic Surgery
Device Facts
| Record ID | K030959 |
| Device Name | BARE LASER FIBER MODELS DBLF-40, DBLF-60, DBLF-60-1, DCLF-600B, DSLF-60, DBLF-100 |
| Applicant | Laser Peripherals, LLC |
| Product Code | GEX · General, Plastic Surgery |
| Decision Date | Apr 25, 2003 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 878.4810 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The Laser Peripherals bare laser fiber is intended for use in laser surgical procedures for cutting, coagulating, or vaporizing in any soft tissue application for which compatible Nd: YAG, KTP and Diode lasers have been cleared.
Device Story
Laser Peripherals Bare Laser Fiber is a surgical accessory used to deliver laser energy to soft tissue. Device functions as a conduit for Nd:YAG, KTP, and Diode laser systems; enables cutting, coagulation, or vaporization of soft tissue during surgical procedures. Operated by physicians in clinical or surgical settings. Device serves as an interface between the laser source and the patient's tissue; facilitates precise energy delivery for surgical intervention. Benefits include versatility across multiple laser wavelengths and soft tissue applications.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Bare laser fiber optic delivery system; compatible with Nd:YAG, KTP, and Diode laser wavelengths. Designed for soft tissue surgical applications (cutting, coagulation, vaporization).
Indications for Use
Indicated for use in soft tissue surgical procedures including cutting, coagulating, or vaporizing, utilizing compatible Nd:YAG, KTP, and Diode lasers.
Regulatory Classification
Identification
(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
Related Devices
- K972272 — LASER PERIPHERALS HOLMIUM BARE FIBERS · Laser Peripherals, LLC · Jul 29, 1997
- K960636 — LASERSONICS ND:YAG CYLINDRICALLY DIFFUSING STERILE DISPOSABLE FIBER · Heraeus Surgical, Inc. · Aug 21, 1996
- K992866 — OPTILITE IX LASER SURGERY ACCESSORIES · Convergent Laser Technologies · Nov 18, 1999
- K124003 — MED-FIBERS SURGICAL LASER FIBER, MED-FIBERS ENDO-ENT LASER PROBES, MED-FIBERS END- AND ASPIRATING LASER PROBES, MED-FIBE · Med-Fibers, Inc. · Jan 17, 2013
- K232769 — BeaMed Laser Surgery Fibers · Bt Beamedical Tachnoogies Ltd. (Beamed) · Dec 6, 2023
Submission Summary (Full Text)
{0}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular pattern around the symbol. The logo is black and white.
Public Health Service
APR 2 5 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Jeffrey M. Stein Research & Development Manager Laser Peripherals LLC 1000 Boone Avenue North, Suite 300 Golden Valley, Minnesota 55427
Re: K030959
Trade/Device Name: Laser Peripherals Bare Laser Fiber Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: March 25, 2003 Received: March 27, 2003
Dear Mr. Stein:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{1}------------------------------------------------
Page 2 - Mr. Jeffrey M. Stein
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Miriam C. Provost
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
## ATTACHMENT B
## Indications for Use Statement
510(k) Number:
K 030959
Device Name:
Laser Peripherals Bare Laser Fiber
Indications
For Use:
The Laser Peripherals bare laser fiber is intended for use in laser surgical procedures for cutting, coagulating, or vaporizing in any soft tissue application for which compatible Nd: YAG, KTP and Diode lasers have been cleared.
## PLEASE DO NOT RIGHT BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
:
OR
Over-The-Counter Use
Muriam C. Provost
(Division Sign-Off) Division of General, Restorative and Neurological Devices
K030959 510(k) Number -